Product details
Catalog number BNC680080-500
Price for BNC680080-500
Size / count 1x 500 µL
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e. g. tamoxifen) therapy. It strongly stains nuclei of epithelial cells in breast carcinomas. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is BNC680080-500.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ER506), CF568 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029a061270361e1017db/msds/bnc680080-500.pdf.
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e. g. tamoxifen) therap
A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.
Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.
Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.